Hyasynth Bio: Organigram : Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company - Form 6-K

(marketscreener.com) December 22, 2021--As an early investor in biosynthesis, Organigram Holdings Inc. , , the parent company of Organigram Inc. , a leading licensed producer of cannabis, and Hyasynth Biologicals Inc. a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis are pleased to announce that Organigram has acquired...https://www.marketscreener.com/quote/stock/ORGANIGRAM-HOLDINGS-INC-65218801/news/Organigram-Makes-Additional-2-5-Million-Investment-in-Hyasynth-Biologicals-a-Leading-Cannabinoid-37399346/?utm_medium=RSS&utm_content=20211222